live attenuated influenza virus vaccine (Flumist) Report issue

Active Ingredient History

NOW
  • Now
Live attenuated influenza vaccine (LAIV) is a type of influenza vaccine in the form of a nasal spray that is recommended for the prevention of influenza. It was developed by the Syrian-American epidemiologist Hunein Maassab.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data
a/california/07/09 live monovalent h1n1 vaccine | caivt | caiv-t | cold-adapted influenza vaccine trivalent | flumist | flumist/b/victoria | flumist/b/yamagata | flumist quadrivalent | influenza vaccine live, intranasal | live attenuated h1n1 influenza vaccine | live attenuated h2n3 influenza virus vaccine | live attenuated h7n9 anhui 2013/aa ca | live attenuated influenza vaccine | live, attenuated influenza vaccine | live attenuated influenza virus | live attenuated monovalent a/17/mallard/netherlands/00/95(h7n3) influenza vaccine | live, trivalent influenza vaccine | medi3250 | medi3414 | medi8662 | quadrivalent live attenuated influenza vaccine | quadrivalent live attenuated influenza vaccine, q/laiv | trivalent flumist

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue